Results 211 to 220 of about 392,797 (346)

1P057 Theoretical study on the self-assembly of satellite tobacco mosaic virus using coarse grained simulation(01C. Protein:Property,Poster)

, 2013
Masato Teranishi, Micke Rusmerryani, Kazutomo Kawaguchi, Hiroaki Saito, Hidemi Nagao   +4 more
openalex   +2 more sources

Session details: ACM HotMobile 2013 posters and demonstrations [PDF]

, 2013
Nilanjan Banerjee
openalex   +1 more source

Poster Presentations [PDF]

Circulation, 1999
openaire   +2 more sources

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Multicomponent intervention increases nutrition knowledge scores in rural China. [PDF]

Sci Rep
He Z, Feng M, Li L, Li J, Li X.
europepmc   +1 more source

2P159 Measurement of three-dimensional trap stiffness in optical tweezers(Molecular motors,Poster Presentations)

, 2007
Isao Terashima, Junichiro Yajima, Kana Mizutani, Tomoko Masaike, Takayuki Nishizaka   +4 more
openalex   +2 more sources

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

1P119 How transcription factor can bypass obstacles? : Molecular simulation approaches(04. Nucleic acid binding proteins,Poster,The 52nd Annual Meeting of the Biophysical Society of Japan(BSJ2014))

, 2014
Mami Saito, Tsuyoshi Terakawa, Shoji Takada   +2 more
openalex   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

The 2025 FELASA Congress in Athens: From Aristotle to AI. [PDF]

Lab Anim (NY)
Franco NH, Kalliokoski O, Voikar V.
europepmc   +1 more source